[PDF] Top 20 TARGETED THERAPIES IN CANCER

... 27. Nakamura H, Mullen JT, Chandrasekhar S, Pawlik TM, Yoon SS, Tanabe KK. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deami- nase for intratumoral ... See full document

... of cancer has driven the field of personalized or “precision” medicine to identify specific tumor characteristics and exploit these features by developing targeted therapies against these ...Several ... See full document

... new targeted therapies for this pathway ...breast cancer (MBC) patients in order to evaluate Erdafitinib, which is an orally administered FGFR inhibitor, in combination with anti-CDK4/6 palbociclib ... See full document

... ovarian cancer is a heterogeneous and aggressive ...ovarian cancer malignancy, new therapeutic options with molecular-targeted agents have become ...molecular-targeted therapies and ... See full document

... on targeted therapies, the drug(s) should be at least temporarily stopped and anti- hypertensive medications (especially angiotensin con vert- ing enzyme (ACE) inhibitors) should be used until LVEF ...the ... See full document

... dividing cancer cells, with foreseeable dose-limiting haematological ...toxicities. Targeted therapies affect specific cellular molecular mechanisms promoting cancer cell survival and ... See full document

... Gastric cancer (GC) is currently the second leading cause of cancer death worldwide; unfortunately, most patients will present with locally advanced or metastatic ...of targeted therapies has ... See full document

... in cancer, the Epidermal Growth Factor system becomes hyperactivated with various mechanisms (ligand overproduction, receptor overproduction, constitutive receptor acti- ...endometrial cancer. It seems that ... See full document

... Esophageal cancer, comprising squamous carcinoma and adenocarcinoma, is a leading cause of cancer-related death in the ...of cancer patients. The molecular analysis of cancer cells has ... See full document

... elderly cancer patients poses many specific problems and it should be revisited in the light of the most recent advances in both diagnosis and treatment of human ...called targeted therapy), appears to be ... See full document

... improve therapies; in recent years, medical research has been fully oriented toward the targeted therapies; we hope to reach also with TNBC what happened with HER2 in BC and with more uncommon ... See full document

... of targeted therapies (Bevacizumab and rarely Cetuximab) in metastatic colic cancers is ...these therapies because of their high ...these therapies, a retrospective and prospective study was ... See full document

... well-studied targeted therapies are drugs that block EGFR, HER-2, and ...colorectal cancer with mutated BRAF, the inhibition may not be clinically beneficial, due to the activation of KRAS, c-Kit or ... See full document

... in cancer can occur through a range of mechanisms, including overexpression (often due to gene amplification), point mutations, partial deletions and auto- crine ligand–receptor stimulation ...in cancer ... See full document

... Lung cancer is the leading cause of cancer death ...lung cancer have led to the development of rationally designed methods of early detection, prevention, and treatment of this ...molecularly ... See full document

... against cancer as it is expressed in the majority of cancer types as well as in cancer stem or stem-like ...in cancer cells while minimizing the effects on normal cells ... See full document

... breast cancer as initial endocrine-based therapy for their metastatic ...breast cancer with different combinations including palbociclib plus letrozole versus letrozole mono- therapy in first-line therapy ... See full document

... breast cancer, together with the identification of the driving genetic alterations and signaling pathways, has led to the clinical development of a number of successful molecular targeted ... See full document

... in cancer bone ...by cancer cells has represented a defeat for oncologic treatments, an early progression signal with poor ...and cancer cells is needed in order to facilitate the design of possible ... See full document

... for therapies (1) that can be used for squamous cell carcinoma patients and (2) that over- come resistance associated with the available targeted ...therapies. Targeted therapies give ... See full document